173 related articles for article (PubMed ID: 29127702)
1. Towards functional selectivity for α6β3γ2 GABA
Treven M; Siebert DCB; Holzinger R; Bampali K; Fabjan J; Varagic Z; Wimmer L; Steudle F; Scholze P; Schnürch M; Mihovilovic MD; Ernst M
Br J Pharmacol; 2018 Feb; 175(3):419-428. PubMed ID: 29127702
[TBL] [Abstract][Full Text] [Related]
2. Subtype selectivity of α+β- site ligands of GABAA receptors: identification of the first highly specific positive modulators at α6β2/3γ2 receptors.
Varagic Z; Ramerstorfer J; Huang S; Rallapalli S; Sarto-Jackson I; Cook J; Sieghart W; Ernst M
Br J Pharmacol; 2013 May; 169(2):384-99. PubMed ID: 23472935
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel positive allosteric modulators and null modulators at the GABAA receptor α+β- interface.
Varagic Z; Wimmer L; Schnürch M; Mihovilovic MD; Huang S; Rallapalli S; Cook JM; Mirheydari P; Ecker GF; Sieghart W; Ernst M
Br J Pharmacol; 2013 May; 169(2):371-83. PubMed ID: 23472852
[TBL] [Abstract][Full Text] [Related]
4. A Benzodiazepine Ligand with Improved GABA
Simeone X; Koniuszewski F; Müllegger M; Smetka A; Steudle F; Puthenkalam R; Ernst M; Scholze P
Mol Pharmacol; 2021 Jan; 99(1):39-48. PubMed ID: 33268553
[TBL] [Abstract][Full Text] [Related]
5. Variations on a scaffold - Novel GABA
Iorio MT; Rehman S; Bampali K; Stoeger B; Schnürch M; Ernst M; Mihovilovic MD
Eur J Med Chem; 2019 Oct; 180():340-349. PubMed ID: 31325782
[TBL] [Abstract][Full Text] [Related]
6. The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study.
Pistis M; Belelli D; Peters JA; Lambert JJ
Br J Pharmacol; 1997 Dec; 122(8):1707-19. PubMed ID: 9422818
[TBL] [Abstract][Full Text] [Related]
7. Differential modulation of GABA(A) receptor function by aryl pyrazoles.
Mascia MP; Ledda G; Orrù A; Marongiu A; Loriga G; Maciocco E; Biggio G; Ruiu S
Eur J Pharmacol; 2014 Jun; 733():1-6. PubMed ID: 24704372
[TBL] [Abstract][Full Text] [Related]
8. GABAA α5 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085.
de Lucas AG; Ahring PK; Larsen JS; Rivera-Arconada I; Lopez-Garcia JA; Mirza NR; Munro G
Biochem Pharmacol; 2015 Feb; 93(3):370-9. PubMed ID: 25542996
[TBL] [Abstract][Full Text] [Related]
9. Delineation of the functional properties and the mechanism of action of AA29504, an allosteric agonist and positive allosteric modulator of GABA
Olander ER; Madjroh N; Bunch L; Söderhielm PC; Jensen AA
Biochem Pharmacol; 2018 Apr; 150():305-319. PubMed ID: 29454619
[TBL] [Abstract][Full Text] [Related]
10. Limiting activity at beta1-subunit-containing GABAA receptor subtypes reduces ataxia.
Gee KW; Tran MB; Hogenkamp DJ; Johnstone TB; Bagnera RE; Yoshimura RF; Huang JC; Belluzzi JD; Whittemore ER
J Pharmacol Exp Ther; 2010 Mar; 332(3):1040-53. PubMed ID: 19940102
[TBL] [Abstract][Full Text] [Related]
11. The anaesthetic action and modulation of GABAA receptor activity by the novel water-soluble aminosteroid Org 20599.
Hill-Venning C; Peters JA; Callachan H; Lambert JJ; Gemmell DK; Anderson A; Byford A; Hamilton N; Hill DR; Marshall RJ; Campbell AC
Neuropharmacology; 1996; 35(9-10):1209-22. PubMed ID: 9014136
[TBL] [Abstract][Full Text] [Related]
12. Molecular mode of action of CGS 9895 at α1 β2 γ2 GABAA receptors.
Maldifassi MC; Baur R; Sigel E
J Neurochem; 2016 Sep; 138(5):722-30. PubMed ID: 27319298
[TBL] [Abstract][Full Text] [Related]
13. Molecular tools for GABA
Simeone X; Siebert DCB; Bampali K; Varagic Z; Treven M; Rehman S; Pyszkowski J; Holzinger R; Steudle F; Scholze P; Mihovilovic MD; Schnürch M; Ernst M
Sci Rep; 2017 Jul; 7(1):5674. PubMed ID: 28720884
[TBL] [Abstract][Full Text] [Related]
14. Defined concatenated α6α1β3γ2 GABA
Simeone X; Iorio MT; Siebert DCB; Rehman S; Schnürch M; Mihovilovic MD; Ernst M
Bioorg Med Chem; 2019 Jul; 27(14):3167-3178. PubMed ID: 31186146
[TBL] [Abstract][Full Text] [Related]
15. GABAA receptor modulation by the novel intravenous general anaesthetic E-6375.
Pau D; Belelli D; Callachan H; Peden DR; Dunlop JI; Peters JA; Guitart X; Gutierrez B; Lambert JJ
Neuropharmacology; 2003 Dec; 45(8):1029-40. PubMed ID: 14614946
[TBL] [Abstract][Full Text] [Related]
16. Receptor subtype-dependent positive and negative modulation of GABA(A) receptor function by niflumic acid, a nonsteroidal anti-inflammatory drug.
Sinkkonen ST; Mansikkamäki S; Möykkynen T; Lüddens H; Uusi-Oukari M; Korpi ER
Mol Pharmacol; 2003 Sep; 64(3):753-63. PubMed ID: 12920213
[TBL] [Abstract][Full Text] [Related]
17. Probing the molecular basis for affinity/potency- and efficacy-based subtype-selectivity exhibited by benzodiazepine-site modulators at GABA
Söderhielm PC; Balle T; Bak-Nyhus S; Zhang M; Hansen KM; Ahring PK; Jensen AA
Biochem Pharmacol; 2018 Dec; 158():339-358. PubMed ID: 30121248
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization and visualization of a GABAA receptor-GFP chimera expressed in Xenopus oocytes.
Bueno OF; Robinson LC; Alvarez-Hernandez X; Leidenheimer NJ
Brain Res Mol Brain Res; 1998 Aug; 59(2):165-77. PubMed ID: 9729362
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology in translation: the preclinical and early clinical profile of the novel α2/3 functionally selective GABA
Nickolls SA; Gurrell R; van Amerongen G; Kammonen J; Cao L; Brown AR; Stead C; Mead A; Watson C; Hsu C; Owen RM; Pike A; Fish RL; Chen L; Qiu R; Morris ED; Feng G; Whitlock M; Gorman D; van Gerven J; Reynolds DS; Dua P; Butt RP
Br J Pharmacol; 2018 Feb; 175(4):708-725. PubMed ID: 29214652
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological properties of GABAA receptors containing gamma1 subunits.
Khom S; Baburin I; Timin EN; Hohaus A; Sieghart W; Hering S
Mol Pharmacol; 2006 Feb; 69(2):640-9. PubMed ID: 16272224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
